Lyra Therapeutics (LYRA) Q2 2023 Earnings

8AugConfirmed
Aug 22
Nov 22
Q4 2022
Q2 2023
-0.44
-0.4
-0.36
-0.32

Details

Expected EPS
-0.42
Actual EPS
-0.36
Surprise EPS
0.06
Surprise Percent
+14.29%

Description

Lyra Therapeutics (LYRA) has reported earnings of -0.36 per share for Q2 2023.

0 Comments

Share your thoughts